ReviewCancers2021

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy.

Giuseppe Schepisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.